Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1993; Volume 264,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 514;
  • You have access
    Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
    E Donato di Paola, B Cusack, M Yamada and E Richelson
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 1-5;
  • You have access
    Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.
    G L DeGraaf, D T Pals, S J Couch and J A Lawson
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 6-10;
  • You have access
    Amelioration of chronic ileitis by nitric oxide synthase inhibition.
    M J Miller, H Sadowska-Krowicka, S Chotinaruemol, J L Kakkis and D A Clark
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 11-16;
  • You have access
    Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
    R Patacchini, L Quartara, P Rovero, C Goso and C A Maggi
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 17-21;
  • You have access
    Chlordiazepoxide block of two types of calcium channels in neuroblastoma cells.
    E Reuveny, D A Twombly and T Narahashi
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 22-28;
  • You have access
    Chronic cocaine disruption of estrous cyclicity in the rat: dose-dependent effects.
    T S King, M S Canez, S Gaskill, M A Javors and R S Schenken
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 29-34;
  • You have access
    Effect of Ca++ channel blockers on energy level and stimulated insulin secretion in isolated rat islets of Langerhans.
    M Ohta, J Nelson, D Nelson, M D Meglasson and M Erecińska
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 35-40;
  • You have access
    Detection and mechanisms of formation of S-(6-purinyl)glutathione and 6-mercaptopurine in rats given 6-chloropurine.
    I Y Hwang and A A Elfarra
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 41-46;
  • You have access
    Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    T J Cicero, B Nock and L O'Connor
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 47-53;
  • You have access
    Cholinergic M2 muscarinic receptor-mediated inhibition of endogenous noradrenaline release from the isolated vascularly perfused rat stomach.
    K Yokotani and Y Osumi
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 54-60;
  • You have access
    Effects of inflammatory mediators on electrolyte transport across the porcine distal colon epithelium.
    T R Traynor, D R Brown and S M O'Grady
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 61-66;
  • You have access
    Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    G R Thomas, H Thibodeaux, W F Bennett, C J Refino, J M Badillo, C J Errett and J A Zivin
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 67-73;
  • You have access
    Pharmacological characterization of the rat hippocampal muscarinic autoreceptor.
    M McKinney, J H Miller and P J Aagaard
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 74-78;
  • You have access
    Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    W J de Ridder and J A Schuurkes
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 79-88;
  • You have access
    Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
    T Yasumori, L Chen, K Nagata, Y Yamazoe and R Kato
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 89-94;
  • You have access
    5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    K Bervoets, J M Rivet and M J Millan
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 95-104;
  • You have access
    Both beta-1 and beta-2 adrenoceptors are coupled to the cyclic AMP system in connecting tubules of rabbit nephron.
    S Homma, E Kusano, S Takeda, N Murayama, Y Asano and T P Dousa
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 105-109;
  • You have access
    Subtypes of somatostatin receptors are expressed in the anterior pituitary cell line GH3.
    K Raynor and T Reisine
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 110-116;
  • You have access
    An intracellular calcium release inhibitor TMB-8 suppresses renal nerve stimulation-induced antinatriuresis in dogs.
    A Ogasawara, H Hisa and S Satoh
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 117-121;
  • You have access
    Dopaminergic agonists impair latent learning in mice: possible modulation by noradrenergic function.
    K Ichihara, T Nabeshima and T Kameyama
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 122-128;
  • You have access
    Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
    G Balasubramaniam, H S Lee and S C Mah
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 129-134;
  • You have access
    An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.
    G D Lopaschuk, R B Wambolt and R L Barr
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 135-144;
  • You have access
    Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
    E R Butelman, C P France and J H Woods
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 145-151;
  • You have access
    Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
    S Ueki, M Seiki, T Yoneta, H Aita, K Chaki, Y Hori, H Morita, E Tagashira and Z Itoh
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 152-157;
  • You have access
    Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    M Oka, Y Noda, Y Ochi, K Furukawa, T Une, S Kurumiya, K Hino and T Karasawa
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 158-165;
  • You have access
    Postnatal development, sex-related difference and hormonal regulation of acetohexamide reductase activities in rat liver and kidney.
    Y Imamura, K Iwamoto, Y Yanachi, T Higuchi and M Otagiri
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 166-171;
  • You have access
    Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    P Ernsberger, T H Damon, L M Graff, S G Schäfer and M O Christen
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 172-182;
  • You have access
    Cocaine tolerance and cross-tolerance.
    J L Katz, J W Griffiths, L G Sharpe, E B De Souza and J M Witkin
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 183-192;
  • You have access
    Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    D J Cushing and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 193-200;
  • You have access
    Rauwolscine induces contraction in the dog mesenteric artery precontracted with KCl and endothelin-1: mediation via 5-hydroxytryptamine1-like receptors.
    Y Shimamoto, H Shimamoto, C Y Kwan and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 201-209;
  • You have access
    Contractile effects of nucleotides in guinea pig isolated, perfused trachea: involvement of respiratory epithelium, prostanoids and Na+ and Cl- channels.
    J S Fedan, J J Belt, L X Yuan and D G Frazer
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 210-216;
  • You have access
    Relaxant effects of nucleotides in guinea pig isolated, perfused trachea: lack of involvement of prostanoids, Cl- channels and adenosine.
    J S Fedan, J J Belt, L X Yuan and D G Frazer
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 217-220;
  • You have access
    N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    E F Domino and J Sheng
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 221-225;
  • You have access
    Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.
    S Fujita, S Umeda, Y Funae, S Imaoka, H Abe, R Ishida, T Adachi, M Masuda, A Kazusaka and T Suzuki
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 226-233;
  • You have access
    Nitric oxide synthase in the autonomic nervous system of canine ileum.
    P Kostka, E Jang, E G Watson, J L Stewart and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 234-239;
  • You have access
    SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    G W Gullikson, M A Virina, R F Loeffler, D C Yang, B Goldstin, S X Wang, C Moummi, D L Flynn and D L Zabrowski
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 240-248;
  • You have access
    Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.
    M E Wolf, F J White, R Nassar, R J Brooderson and M R Khansa
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 249-255;
  • You have access
    Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    J W Ferkany, G S Hamilton, R J Patch, Z Huang, S A Borosky, D L Bednar, B E Jones, R Zubrowski, J Willetts and E W Karbon
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 256-264;
  • You have access
    Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester.
    M J Winn, N K Asante and D D Ku
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 265-270;
  • You have access
    Further evidence that the guinea pig tracheal contractile serotonergic receptor is a 5-hydroxytryptamine2 receptor: use of 5-methyltryptamine and dipropyl-5-carboxamidotryptamine.
    S W Watts and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 271-275;
  • You have access
    Activation of protein kinase C rapidly down-regulates naloxone-resistant receptors for beta-endorphin on U937 cells.
    N A Shahabi and B M Sharp
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 276-281;
  • You have access
    Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
    R A Gonzales, L C Roper and S L Westbrook
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 282-288;
  • You have access
    Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens.
    K D Youngren, D A Daly and B Moghaddam
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 289-293;
  • You have access
    Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells.
    C J Heyser, R E Hampson and S A Deadwyler
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 294-307;
  • You have access
    Identification of an orally active, nonpeptidyl oxytocin antagonist.
    D J Pettibone, B V Clineschmidt, M T Kishel, E V Lis, D R Reiss, C J Woyden, B E Evans, R M Freidinger, D F Veber and M J Cook
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 308-314;
  • You have access
    Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. VI. Effect of the calcium channel blocker nimodipine on zidovudine kinetics in monkeys.
    J M Gallo, A R Swagler, M Mehta and M Qian
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 315-320;
  • You have access
    Pharmacological induction of physiologically active nerve growth factor in rat peripheral nervous system.
    K Kaechi, Y Furukawa, R Ikegami, N Nakamura, F Omae, Y Hashimoto, K Hayashi and S Furukawa
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 321-326;
  • You have access
    Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
    Y Takano and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 327-335;
  • You have access
    Alterations by a thromboxane A2 analog (U46619) of calcium dynamics in isolated rat cardiomyocytes.
    P Hoffmann, I Heinroth-Hoffmann and M Toraason
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 336-344;
  • You have access
    Rat kidney endothelin receptors in ischemia-induced acute renal failure.
    P Nambi, M Pullen, M Jugus and M Gellai
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 345-348;
  • You have access
    Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain.
    B Nock, A L Giordano, B W Moore and T J Cicero
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 349-359;
  • You have access
    A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    W K Bickel, A H Oliveto, J B Kamien, S T Higgins and J R Hughes
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 360-367;
  • You have access
    Buprenorphine prevents and reverses the expression of chronic etorphine-induced sensitization of adenylyl cyclase in SK-N-SH human neuroblastoma cells.
    J M Thomas and B B Hoffman
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 368-374;
  • You have access
    Differential inhibition of cholinergic and noncholinergic neurogenic contractions by mu opioid and alpha-2 adrenergic agonists in guinea pig ileum.
    J J Galligan
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 375-383;
  • You have access
    Neurally mediated actions of leukotrienes on ion transport in guinea pig distal colon.
    D M Hammerbeck and D R Brown
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 384-390;
  • You have access
    Ascending enteric reflex contraction: roles of acetylcholine and tachykinins in relation to distension and propagation of excitation.
    P Holzer, W Schluet and C A Maggi
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 391-396;
  • You have access
    Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    T Hohlfeld, H Strobach and K Schrör
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 397-405;
  • You have access
    Studies on the role of sodium on the synthesis of dopamine in the rat kidney.
    P Soares-da-Silva, M H Fernandes and M Pestana
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 406-414;
  • You have access
    Autoradiographic mapping of M3 muscarinic receptors in the rat brain.
    J K Zubieta and K A Frey
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 415-422;
  • You have access
    A specific antisense oligodeoxynucleotide to mRNAs encoding receptors with seven transmembrane spanning regions decreases muscarinic m2 and gamma-aminobutyric acidB receptors in rat cerebellar granule cells.
    I Holopainen and W J Wojcik
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 423-430;
  • You have access
    Autoradiographic localization of dopamine D1 receptors in the human kidney.
    A Ricci, S Escaf, J A Vega and F Amenta
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 431-437;
  • You have access
    Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat.
    T M Badger, M J Ronis, C K Lumpkin, C R Valentine, M Shahare, D Irby, J Huang, C Mercado, P Thomas and M Ingelman-Sundberg
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 438-447;
  • You have access
    Long-term suppression of insulin-like growth factor-1 in rats after in utero ethanol exposure: relationship to somatic growth.
    C R Breese, A D'Costa, R L Ingram, J Lenham and W E Sonntag
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 448-456;
  • You have access
    Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32.
    M D Maines, R D Mayer, J F Ewing and W K McCoubrey
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 457-462;
  • You have access
    Tetrahydroaminoacridine is neurotrophic and promotes the expression of muscarinic receptor-coupled phosphoinositide turnover in differentiating cerebellar granule cells.
    K Sunaga, D M Chuang and R Ishitani
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 463-468;
  • You have access
    Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution.
    S Kamei, H Okada, Y Inoue, T Yoshioka, Y Ogawa and H Toguchi
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 469-474;
  • You have access
    Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.
    C Jin, J O Miners, K J Lillywhite and P I Mackenzie
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 475-479;
  • You have access
    Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
    K Rasmussen, J F Czachura, M E Stockton and J J Howbert
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 480-488;
  • You have access
    Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.
    R Bals-Kubik, A Ableitner, A Herz and T S Shippenberg
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 489-495;
  • You have access
    Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
    J Nagakawa, K Hirota, I Hishinuma, K Miyamoto, J Sonoda, T Yamanaka, K Katayama and I Yamatsu
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 496-500;
  • You have access
    Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    S P Roux, T B Tschopp, H Kuhn, B Steiner and P Hadváry
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 501-508;
  • You have access
    Neurogenic plasma extravasation in the rat nasal mucosa is potentiated by peptidase inhibitors.
    G Petersson, E Bacci, D M McDonald and J A Nadel
    Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 509-514;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 264, Issue 1
1 Jan 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics